Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 15, 2024.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
Conformal Medical this week reported "encouraging" results for its left atrial appendage occlusion device. Fast Five hosts Danielle Kirsh and Sean Whooley discuss what the device does and what doctors think about the device.
Autonomix has completed its first procedures in its pancreatic cancer ablation trial. Learn what the trial will assess, what the technology does and how optimistic executives are.
Axonics won CE mark approval for its fourth-generation rechargeable sacral neuromodulation system. Whooley talks about what the device does and some of the other news Axonics has had recently.
SafeGuard Surgical won an FDA breakthrough nod for its biodegradable stent. Hear more about the stent, which has backing from an NFL quarterback.
Edwards reported "excellent" outcomes with its latest Sapien TAVR study. The Fast Five hosts talk about some of the data points that stuck out.
All content for Fast Five Medtech News Podcast is the property of MassDevice and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 15, 2024.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
Conformal Medical this week reported "encouraging" results for its left atrial appendage occlusion device. Fast Five hosts Danielle Kirsh and Sean Whooley discuss what the device does and what doctors think about the device.
Autonomix has completed its first procedures in its pancreatic cancer ablation trial. Learn what the trial will assess, what the technology does and how optimistic executives are.
Axonics won CE mark approval for its fourth-generation rechargeable sacral neuromodulation system. Whooley talks about what the device does and some of the other news Axonics has had recently.
SafeGuard Surgical won an FDA breakthrough nod for its biodegradable stent. Hear more about the stent, which has backing from an NFL quarterback.
Edwards reported "excellent" outcomes with its latest Sapien TAVR study. The Fast Five hosts talk about some of the data points that stuck out.
iRhythm closes offering worth more than $660M; FDA accepts Onward BCI into advisory program
Fast Five Medtech News Podcast
11 minutes 2 seconds
1 year ago
iRhythm closes offering worth more than $660M; FDA accepts Onward BCI into advisory program
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 12, 2024.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
Boston Scientific reported positive results for the agent drug-coated balloon study. Fast Five hosts Danielle Kirsh and Sean Whooley talk about the technology and the data points that stick out.
Medtronic is highlighting the global performance of its MiniMed 780G automated insulin delivery system. Hear about what the new data highlights and some of the most compelling data the company highlighted.
The FDA has cleared Pulse Biosciences' pulsed field ablation electrode technology. Whooley talks about what the PFA electrode technology does and some of the optimism that executives have.
Onward was accepted into an FDA advisory program. The Fast Five hosts talk about the technology that got them into the advisory program and what the acceptance means.
iRhythm closed an offering worth more than $660 million. Learn more about what is included in this offering and what the company plans to use the proceeds for.
Fast Five Medtech News Podcast
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 15, 2024.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
Conformal Medical this week reported "encouraging" results for its left atrial appendage occlusion device. Fast Five hosts Danielle Kirsh and Sean Whooley discuss what the device does and what doctors think about the device.
Autonomix has completed its first procedures in its pancreatic cancer ablation trial. Learn what the trial will assess, what the technology does and how optimistic executives are.
Axonics won CE mark approval for its fourth-generation rechargeable sacral neuromodulation system. Whooley talks about what the device does and some of the other news Axonics has had recently.
SafeGuard Surgical won an FDA breakthrough nod for its biodegradable stent. Hear more about the stent, which has backing from an NFL quarterback.
Edwards reported "excellent" outcomes with its latest Sapien TAVR study. The Fast Five hosts talk about some of the data points that stuck out.
